Dr. James W. Lee
Claim this profileVirtua Samson Cancer Center
About James W. Lee
Education:
- Earned an MD from Cornell University Medical College.
Experience:
- Board Certified in Internal Medicine and Oncology.
- Has over 30 years of experience in patient care.
- Joined Hematology Oncology Associates, SJ in 2004, serving the Mount Holly community.
- Completed an internship at Georgetown University Hospital and received training at the National Cancer Institute (NCI).
- Actively participates in clinical trials to advance cancer diagnosis and treatment techniques.
Area of expertise
Lung Cancer
James W. Lee has run 15 trials for Lung Cancer. Some of their research focus areas include:
Non-Small Cell Lung Cancer
James W. Lee has run 13 trials for Non-Small Cell Lung Cancer. Some of their research focus areas include:
Affiliated Hospitals
Virtua Samson Cancer Center
Virtua Voorhees
Clinical Trials James W. Lee is currently running
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting
2 awards
Phase 3
27 criteria
Tepotinib + Ramucirumab
for Lung Cancer
This phase II Expanded Lung-MAP treatment trial tests tepotinib with or without ramucirumab for the treatment of patients with advanced non-small cell lung cancer that has spread from where it first started (primary site) to other places in the body (stage IV) or that has come back after a period of improvement (recurrent). Tepotinib is used in patients whose cancer has a mutated (changed) form of a gene called MET. It is in a class of medications called kinase inhibitors. It works by blocking the action of the abnormal MET protein that signals tumor cells to multiply. This helps slow or stop the spread of tumor cells. Ramucirumab is a monoclonal antibody that may prevent the growth of new blood vessels that tumors need to grow. Giving tepotinib with ramucirumab may lower the chance of the cancer from growing or spreading in patients with stage IV or recurrent non-small cell lung cancer.
Recruiting
1 award
Phase 2
4 criteria
More about James W. Lee
Clinical Trial Related
5 years of experience running clinical trials · Led 18 trials as a Principal Investigator · 4 Active Clinical Trials
Treatments James W. Lee has experience with
- Pembrolizumab
- Carboplatin
- Ramucirumab
- Pemetrexed
- Selpercatinib
- Pemetrexed Disodium
Breakdown of trials James W. Lee has run
Lung Cancer
Non-Small Cell Lung Cancer
Lung Carcinoma
Anaplastic Large Cell Lymphoma
ALK Gene Rearrangement
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does James W. Lee specialize in?
James W. Lee focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is James W. Lee currently recruiting for clinical trials?
Yes, James W. Lee is currently recruiting for 4 clinical trials in Moorestown New Jersey. If you're interested in participating, you should apply.
Are there any treatments that James W. Lee has studied deeply?
Yes, James W. Lee has studied treatments such as Pembrolizumab, Carboplatin, Ramucirumab.
What is the best way to schedule an appointment with James W. Lee?
Apply for one of the trials that James W. Lee is conducting.
What is the office address of James W. Lee?
The office of James W. Lee is located at: Virtua Samson Cancer Center, Moorestown, New Jersey 08057 United States. This is the address for their practice at the Virtua Samson Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.